Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study (vol 18, pg 3748, 2000)

被引：3

作者：

Vergote, I

Bonneterre, J.

Thuerlimann, B.

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 03期

关键词：

D O I：

10.1200/JCO.2011.41.3302

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：343 / 343

页数：1

相关论文

共 1 条

[1] Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study [J].

Bonneterre, J ;

Thürlimann, B ;

Robertson, JFR ;

Krzakowski, M ;

Mauriac, L ;

Koralewski, P ;

Vergote, I ;

Webster, A ;

Steinberg, M ;

von Euler, M .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) :3748-3757